LALuigi Angrisani

Luigi Angrisani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Luigi Angrisani has a total of 210 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Metabolic Bariatric Surgery for Cancer Prevention and Risk Reduction in Patients with Obesity: A GRADE-Based International Federation for the Surgery and Other Therapies for Obesity (IFSO) Position Statement

    by Amanda Belluzzi, Maurizio De Luca, Antonio Vitiello, Ricardo Cohen, Ali Aminian, Paulina Salminen, Abdelrahman Nimeri, Nicola Di Lorenzo, Luigi Angrisani, Catalin Copaescu, et al.


  • Open Access

    Long-Term Anatomical Durability and Clinical Outcomes of Concomitant Laparoscopic Sleeve Gastrectomy and Hiatal Hernia Repair: Up to 10-Year Multicenter Analysis

    by Francesco Maria Carrano, Beatrice De Luca, Francesco Angrisani, Giulia Griguolo, Fabio Cesare Campanile, Nicola Perrotta, Cristian Eugeniu Boru, Luigi Angrisani, Gianfranco Silecchia

    Background: Hiatal hernia is common in patients with severe obesity undergoing metabolic bariatric surgery. Although concomitant hiatal hernia repair during laparoscopic sleeve gastrectomy has been widely adopted, long-term data beyond 5 years remain limited, and the clinical relevance of anatomical recurrence is still poorly defined. Objectives: To evaluate the 10-year recurrence rate, predictors of failure, and clinical outcomes following concomitant sleeve gastrectomy and hiatal hernia repair. Methods: This retrospective multicenter cohort study analyzed 111 patients who underwent sleeve gastrectomy with concomitant hiatal hernia repair between 2014 and 2015. Complete-case analysis included only patients with assessable recurrence status at follow-up. The primary outcome was anatomical recurrence (> 2 cm transhiatal migration of the gastric sleeve). Secondary outcomes included reintervention, gastroesophageal reflux disease (GERD), and weight loss. Results: Among 111 patients, 108 were analyzed. Mean age was 50.1 ± 11.6 years, 80.6% female, mean baseline BMI 42.7 ± 5.8 kg/m², and mean follow-up was 93.0 ± 22.7 months (7.7 ± 1.9 years). Hernia recurrence occurred in 14 patients (13.0%). Among these, 5 (35.7%) underwent reintervention, while 9 (64.3%) were managed conservatively. Freedom from recurrence was 98.1% at 5 years and 68.9% at 10 years, although the 10-year estimate should be interpreted cautiously. Hernia size ≥ 5 cm and postoperative GERD were associated with recurrence (OR 5.0; 95% CI 1.2-20.0; P=0.035; OR 4.97; 95% CI 1.56–17.53; p = 0.008). Reintervention was required in 11 patients (10.2%), all with symptomatic GERD. Conclusions: Concomitant sleeve gastrectomy and hiatal hernia repair were associated with acceptable long-term outcomes in this multicenter cohort. Reintervention was more often associated with postoperative reflux-related symptoms than with anatomical recurrence alone, while many anatomical recurrences were managed conservatively.


  • Global Variability in Children and Adolescent Metabolic Bariatric Surgery Guidelines: A Worldwide IFSO Survey

    by Juan Pujol-Rafols, Daniel M. Felsenreich, Júlia Carmona‐Maurici, Gerhard Prager, Ricardo V. Cohen, Natan Zundel, Chetan Parmar, Aayed Alqahtani, Catalin Copaescu, Pablo Omelanczuk, et al.

    Introduction Children and adolescent (pediatric) obesity is a growing global health challenge, with traditional weight-loss strategies often proving ineffective. Metabolic and bariatric surgery (MBS) is increasingly considered for pediatric patients with severe obesity. The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) published its latest recommendations on pediatric MBS in 2022. However, their adoption may vary across countries due to differences in healthcare systems, cultural norms, and resources. Aim To assess global variability in indications, practices, and healthcare coverage for pediatric MBS among IFSO member countries, and to evaluate adherence to international guidelines. Method A descriptive survey was conducted among IFSO-affiliated national societies using a 17-item online questionnaire covering indications for pediatric MBS, recommended techniques, referral pathways, and financial coverage. Results Of 76 societies, 66 (86.8%) responded. Most (75.8%) reported having national guidelines; 46.0% followed IFSO’s BMI-based indications’ criteria, while 14.0% applied stricter thresholds (BMI>40Kg/m2), and 8.0% did not recommend MBS outside clinical trials. Additionally, 31.8% required a minimum level of physical maturity on the basis of age, pubertal stage or bone growth. Sleeve gastrectomy was the most commonly recommended technique (69.2%). Pediatricians and parents were the most frequent referrers (35.0% and 33.0%, respectively). Some form of financial coverage was reported in 59.1% of countries, with significant disparities between regions. Conclusion Despite international recommendations, significant variability persists in pediatric MBS practices worldwide. Standardizing criteria and improving access to care are essential to ensure equitable and evidence-based treatment for children and adolescents with severe obesity.


  • Same-day Discharge Metabolic and Bariatric Surgery: a GRADE-based International Federation for the Surgery and Other Therapies for Obesity (IFSO) Position Statement

    by Mohammad Kermansaravi, Ricardo V Cohen, Scott A Shikora, Sonja Chiappetta, Chetan Parmar, Kamal Mahawar, Ali Aminian, Bruno Dillemans, Matteo Monami, Amanda Belluzzi, et al.


  • Scientific production on robotic metabolic and bariatric surgery: a comprehensive bibliometric analysis on its current world status

    by Yeisson Rivero-Moreno, Maria Paula Corzo, Aman Goyal, Juan Camilo Roa-Maldonado, Sophia Echevarria, Steven Elzein, Enrique Elli, Rana Pullatt, Sjaak Pouwels, Beniamino Pascotto, et al.

    Background: Robotic metabolic and bariatric surgery (RMBS) has emerged as an innovative approach in the treatment of severe obesity by combining the ergonomic precision of robotic technology and instrumentation with the established benefits of weight loss surgery. This study employs a bibliometric approach to identify local research trends and worldwide patterns in RMBS. Materials & Methods: The research methodology used “robotic” and “metabolic” or “bariatric surgery” to search Web of Science. Articles that were published prior to December 31st, 2023, were included. The analyses were developed using the Rayyan and Bibliometric, in R Studio. Results: 265 articles from 51 different journals were included. Scientific production of RMBS experienced a significant annual growth rate of 21.96% from 2003 to 2023, resulting in an average of 12.6 papers published per year. A high correlation (R2 = 0.94) was found between the year and number of articles. The mean number of citations per document was 13.25. Approximately 90% of the journals were classified as zone 3, according to the Bradford categorization. International collaboration was identified in 10.57% of cases, with the University of California and the University of Illinois being the most common organizations. The countries with the highest number of corresponding authors, in descending order, were the United States of America, China, and Switzerland. Conclusion: Scientific production in RMBS has experienced sustained growth since the first original publications in 2003. While it has not yet reached the volume, impact, and international collaboration seen in studies related to non-robotic metabolic and bariatric surgery, RBMS holds potential that remains to be explored. Graphical abstract


  • Open Access

    Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects

    by Maurizio De Luca, Amanda Belluzzi, Paulina Salminen, Marco Bueter, Juan Pujol-Rafols, Nasser Sakran, Christine Stier, Halit Eren Taskin, Sonja Chiappetta, Francesco Maria Carrano, et al.

    Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop the present guidelines. The panel formulated a series of clinical questions (based on the patient, intervention, comparison, and outcome conceptual framework), which have been voted on and approved. A GRADE methodology will be applied to assess the quality of evidence and formulate recommendations employed to minimize selection and information biases. This approach aims to enhance the reliability and validity of recommendations, promoting greater adherence to the best available evidence. Results: These guidelines are intended for adult patients with a body mass index (BMI) ≥ 30 kg/m2 who are candidates for metabolic bariatric surgery (MBS). The expert panel responsible for developing these guidelines comprised 25 panelists (92% were bariatric surgeons) and 3 evidence reviewers, with an average age of 50.1 ± 10.2 years. The panel focused on 3 key questions regarding the combined use of structured lifestyle interventions, approved obesity management medications, and endoscopic weight loss procedures with MBS. Conclusions: The complexity of obesity as a chronic disease requires a comprehensive knowledge of all the available and feasible therapeutic options. The IFSO-EC society felt the urgent need to develop methodologically valid guidelines to give a full picture and awareness of the possible surgical and non-surgical therapeutic strategies employed with a multimodal approach.


  • Top Cited Papers
    Open Access

    Scientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (IFSO/ASMBS)

    by Maurizio De Luca, Scott Shikora, Dan Eisenberg, Luigi Angrisani, Chetan Parmar, Aayed Alqahtani, Ali Aminian, Edo Aarts, Wendy A. Brown, Ricardo V. Cohen, et al.


  • Top Cited Papers
    Open Access

    IFSO Worldwide Survey 2020–2021: Current Trends for Bariatric and Metabolic Procedures

    by Luigi Angrisani, Antonella Santonicola, Paola Iovino, Rossella Palma, Lilian Kow, Gerhard Prager, Almino Ramos, Scott Shikora, Collaborative Study Group for the IFSO Worldwide Survey

    Purpose: This IFSO survey aims to describe the current trends of metabolic and bariatric surgery (MBS) reporting on the number and types of surgical and endoluminal procedures performed in 2020 and 2021, in the world and within each IFSO chapter. Methods: All national societies belonging to IFSO were asked to complete the survey form. The number and types of procedures performed (surgical and endoluminal interventions) from 2020 to 2021 were documented. A special section focused on the impact of COVID-19, the existence of national protocols for MBS, the use of telemedicine, and any mortality related to MBS. A trend analysis of the data, both worldwide and within each IFSO chapter, was also performed for the period between 2018 and 2021. Results: Fifty-seven of the 74 (77%) IFSO national societies submitted the survey. Twenty-four of the 57 (42.1%) reported data from their national registries. The total number of surgical and endoluminal procedures performed in 2020 was 507,806 and in 2021 was 598,834. Sleeve gastrectomy (SG) remained the most performed bariatric procedure. Thirty national societies (52%) had regional protocols for MBS during COVID-19, 61.4% supported the use of telemedicine, and only 47.3% collected data on mortality after MBS in 2020. These percentages did not significantly change in 2021 (p > 0.05). Conclusions: The number of MBS markedly decreased worldwide during 2020. Although there was a positive trend in 2021, it did not reach the values obtained before the COVID-19 pandemic. SG continued to be the most performed operation. Adjustable gastric banding (AGB) continues to decrease worldwide. Graphical


  • Revisional Surgery after Laparoscopic Adjustable Gastric Banding

    by Luigi Angrisani, Rossella Palma, Erica Archivolti, William J. Hawkins, Myutan Kulendran

  • Open Access

    Novel Impedance-pH Parameters in Pre-Bariatric Assessment of Patients: A Pilot Study

    by Mario Gagliardi, Antonella Santonicola, Rossella Palma, Luigi Angrisani, Nigel J. Trudgill, Paola Iovino

    Novel impedance-pH parameters, Mean Nocturnal Baseline Impedance (MNBI) and Post-Reflux Swallow-Induced Peristaltic Wave (PSPW) index, have been proposed to improve the gastro-esophageal reflux disease (GERD) diagnostic yield. This study aims to determine the integrity of the esophageal epithelial barrier and chemical clearance using these novel parameters and to correlate them with acid exposure time (AET) and acid clearance time (ACT) in obese patients who are candidates for bariatric surgery (BS). Twenty impedance-pHmetry tracings of patients prior to BS were reviewed. Nine (45%) patients with a conclusive diagnosis of GERD had significantly higher ACT, lower MNBI in the distal esophagus and lower PSPW indexes compared to obese patients without GERD. Moreover, 100% of obese patients with GERD had a pathological ACT compared to obese patients without GERD (p = 0.003). However, the percentage of pathological MNBI and PSPW index did not differ between obese patients with and without GERD. The PSPW index and MNBI of the distal channel significantly correlated with ACT and AET. Further studies are needed to assess the role of time-consuming novel parameters in the routine evaluation of morbidly obese patients candidates for BS. The value of acid clearance time is confirmed as a relevant impedance-pH parameter in these patients.